Martin Riediker

Apersys AG is a Swiss medtech startup stemming from the Liver4Life project incubated at the Wyss Zurich Translational Center and supported by ETH and UZH. We are a multidisciplinary team of surgeons, biologists, entrepreneurs, and engineers, with the objective of developing the most advanced perfusion system to address organ shortages.

Perseo pharma takes its name from Perseus, the hero of Greek mythology who, by wearing the Cap of Invisibility, was able to slay the Gorgon Medusa whose gaze was turning onlookers into stone. Perseo pharma’s therapeutic enzymes, with their stealth coating, are able to invisibly reach their targets so as to slay the disease.

INOFEA empowers enzymes. Enzyme stabilization and protection is INOFEA`s core business. We have developed an innovative and patented platform technology to provide enzymes with a protective shield. We unlock the full potential value of enzymes, providing a seamless level of enhanced properties, unlike any other existing technology. This makes your enzymes 10 times more stable and they can be re-used easily. Our highly resistant enzymes support Biocatalysis including bioconjugation, diagnostics (bioanalysis) or can be formulated as active ingredients. Our technology addresses a wide range of biotech applications for the industry and demonstrated substantial benefits to customers in pharma, food processing, specialty chemicals and consumer care.

Apersys AG is a Swiss medtech startup stemming from the Liver4Life project incubated at the Wyss Zurich Translational Center and supported by ETH and UZH. We are a multidisciplinary team of surgeons, biologists, entrepreneurs, and engineers, with the objective of developing the most advanced perfusion system to address organ shortages.

We supply the most reliable biometric recognition devices, seamlessly integrated with world-leading access control and time and attendance solutions. Touchless Biometric Systems is an award-winning supplier of biometric recognition hardware and solutions. We have one of the widest portfolios of products in the market, ensuring that we are able to provide solutions offering outstanding performance, even in the most challenging of environments. At the forefront of our product portfolio is our 3D Terminal; a contactless, 3D fingerprint reader that, unlike traditional touch-based fingerprint readers, captures the entire fingerprint. This technology was the first to be released by TBS and continues to be widely recognised as the most accurate form of fingerprint identification. To compliment the portfolio, we also offer multi-spectral, optical and portable fingerprint devices, contactless iris recognition with automatic face detection, 3D anti-tailgating and card readers. Our products are used by a wide range of industries, all of whom are looking for accurate and convenient time-clocking solutions. These industries include financial institutions, Universities, Ministries, critical infrastructure and facility management, amongst others. Our philosophy is to invest in R&D and be able to provide the right solution for every application. TBS is a Swiss-based company, with our manufacturing facility and Head Office located just outside of Zurich, in the heart of Switzerland. We pride ourselves on bringing together best-of-breed technologies that not only look appealing, but also perform with the reliability and precision that you would expect from Swiss engineering. Our close collaboration with our integration partners, and our certified training for integrators ensures customer satisfaction and is why we continue to be recommended as the best in the industry. For more information, please call us on +41 (0)55 533 20 00 or send us an email to tbs@tbs-biometrics.com.

Perseo pharma takes its name from Perseus, the hero of Greek mythology who, by wearing the Cap of Invisibility, was able to slay the Gorgon Medusa whose gaze was turning onlookers into stone. Perseo pharma’s therapeutic enzymes, with their stealth coating, are able to invisibly reach their targets so as to slay the disease.